Abstract
In the tumor ecosystem, we recognize local and distant environments, and the circulation through which the exchange of messages occurs. Communication is largely mediated through secretory protein signals and non-conventional secretory mechanisms such as the release of extracellular vesicles containing protein and RNA payloads. A plethora of antibody microarrays and mass spectrometry platforms are available to perform protein secretome analysis. Further application of nanomaterials will improve sensitivity and robustness to detect low-abundance proteins. The term tumor secretome is very broad; by using the ecosystem concept we introduce different in vivo and ex vivo sample types that can be employed for proteomics. These include tumor interstitial fluid (TIF), tumor proximal body fluids, organotypic tissue slices and exposure of a fresh surgical specimen to biotinylation, followed by streptavidin precipitation. In vitro models may mimic the tumor ecosystem or can be simplified by incorporating one cell type from the tumor ecosystem. We believe that models allowing the study of secretomes from tumor ecosystems will provide us insights in tumor biology, biomarkers (prognostic/predictive) and novel therapeutic targets.
Keywords: CAF, exosome, proteomics, stroma, TIF.
Current Proteomics
Title:Protein Secretome Analysis of Evolving and Responding Tumor Ecosystems
Volume: 10 Issue: 2
Author(s): Olivier De Wever, Astrid De Boeck, Dawn Maynard, Marc Bracke and An Hendrix
Affiliation:
Keywords: CAF, exosome, proteomics, stroma, TIF.
Abstract: In the tumor ecosystem, we recognize local and distant environments, and the circulation through which the exchange of messages occurs. Communication is largely mediated through secretory protein signals and non-conventional secretory mechanisms such as the release of extracellular vesicles containing protein and RNA payloads. A plethora of antibody microarrays and mass spectrometry platforms are available to perform protein secretome analysis. Further application of nanomaterials will improve sensitivity and robustness to detect low-abundance proteins. The term tumor secretome is very broad; by using the ecosystem concept we introduce different in vivo and ex vivo sample types that can be employed for proteomics. These include tumor interstitial fluid (TIF), tumor proximal body fluids, organotypic tissue slices and exposure of a fresh surgical specimen to biotinylation, followed by streptavidin precipitation. In vitro models may mimic the tumor ecosystem or can be simplified by incorporating one cell type from the tumor ecosystem. We believe that models allowing the study of secretomes from tumor ecosystems will provide us insights in tumor biology, biomarkers (prognostic/predictive) and novel therapeutic targets.
Export Options
About this article
Cite this article as:
Wever De Olivier, Boeck De Astrid, Maynard Dawn, Bracke Marc and Hendrix An, Protein Secretome Analysis of Evolving and Responding Tumor Ecosystems, Current Proteomics 2013; 10 (2) . https://dx.doi.org/10.2174/15701646112099990003
DOI https://dx.doi.org/10.2174/15701646112099990003 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
Call for Papers in Thematic Issues
Mass spectrometry data acquisition and analysis for proteomics
The Thematic Issue on "Mass spectrometry data acquisition and analysis for proteomics" aims to explore the latest advancements and challenges in the field of proteomics through the lens of mass spectrometry. Proteomics, the large-scale study of proteins and their functions, plays a crucial role in understanding various biological processes and ...read more
Peptides: State-of-Art and Commercialisation Hurdles
The Editors of the Current Proteomics (CP) journal are highly privileged to welcome scientists to submit their scientific research and review articles to be considered for publication in the upcoming thematic issue. The topics should cover various aspects of peptides in regard to their synthetic methodologies, formulation approaches, pharmacological challenges, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Improving Cancer Chemotherapy with Modulators of ABC Drug Transporters
Current Drug Targets Gene Electrotransfer to Skin; Review of Existing Literature and Clinical Perspectives
Current Gene Therapy Targeting Never-In-Mitosis-A Related Kinase 5 in Cancer: A Review
Current Medicinal Chemistry Statins and Type 2 Diabetes Mellitus: An Update After 1 Year
Current Pharmaceutical Design Psychiatric Side Effects of Interferon Treatment
Current Drug Safety An Overview on Fibroblast Growth Factors: Structural, Functional and Therapeutic Implications
Current Proteomics Use of E. coli Purine Nucleoside Phosphorylase in the Treatment of Solid Tumors
Current Pharmaceutical Design Retracted: Potential Health Benefits of Broccoli- A Chemico-Biological Overview
Mini-Reviews in Medicinal Chemistry Micro Arrays and Biochips: Applications and Potential in Genomics and Proteomics
Current Genomics Quantization of Angiogenesis and Image Analysis
Current Angiogenesis (Discontinued) Antineoplastic Potential of Medicinal Plants
Recent Patents on Biotechnology Targeting CSCs in Tumor Microenvironment: The Potential Role of ROS-Associated miRNAs in Tumor Aggressiveness
Current Stem Cell Research & Therapy Manipulation of the Immune System for Cancer Defeat: A Focus on the T Cell Inhibitory Checkpoint Molecules
Current Medicinal Chemistry Leukocyte P2 Receptors: A Novel Target for Anti-inflammatory and Antitumor Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders Tumor Suppression by DNA Base Excision Repair
Mini-Reviews in Medicinal Chemistry The Role of miR-129-5p in Cancer: A Novel Therapeutic Target
Current Molecular Pharmacology Inhibition of Apoptosis in Pediatric Cancer by Survivin
Current Pediatric Reviews Systemic Approach to the Study of Complex Bone Disorders at the Whole- Genome Level
Current Genomics The Importance of Guidelines in the Development and Application of Probiotics
Current Pharmaceutical Design Urine Cells-derived iPSCs: An Upcoming Frontier in Regenerative Medicine
Current Medicinal Chemistry